Associated Papers
Lymphoid enhancer-binding factor 1 (LEF1) immunostaining as a surrogate for β-catenin (CTNNB1) mutations.
Hewer E et al.
Journal of Clinical Pathology, 2025
39653501 (PubMed )
Supplement: jcp-79-1-s002.pdf
Novel germline variants of CDKN1B and CDKN2C identified during screening for familial primary hyperparathyroidism.
Mazarico-Altisent I et al.
Journal of Endocrinological Investigation, 2023
36334246 (PubMed )
Supplement: 40618_2022_1948_MOESM1_ESM.xlsx › Supplementary_material
Multiple endocrine neoplasia type 4: a new member of the MEN family.
Singeisen H et al.
Endocrine Connections, 2023
Genetics of Cushing's Syndrome.
Hernández-Ramírez LC et al.
Endocrinology and Metabolism Clinics of North America, 2018
Landscape of CDKN1B Mutations in Luminal Breast Cancer and Other Hormone-Driven Human Tumors.
Cusan M et al.
Frontiers in Endocrinology, 2018
MEN4 and CDKN1B mutations: the latest of the MEN syndromes.
Alrezk R et al.
Endocrine-related Cancer, 2017
p27Kip1 and human cancers: A reappraisal of a still enigmatic protein.
Bencivenga D et al.
Cancer Letters, 2017
A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation.
Buzzola R et al.
Cardiorenal Medicine, 2016
Functional characterization of a CDKN1B mutation in a Sardinian kindred with multiple endocrine neoplasia type 4 (MEN4).
Pardi E et al.
Endocrine Connections, 2015
p27kip1: a new multiple endocrine neoplasia gene?
Marinoni I et al.
Neuroendocrinology, 2011
A novel germline CDKN1B mutation causing multiple endocrine tumors: clinical, genetic and functional characterization.
Molatore S et al.
Human Mutation, 2010
Select a paper to view details